On the other hand, another previous report showed that GPNMB inhibition by a neutralizing antibody or liver-specific knockdown reduced body weight and improved obesity-related metabolic disorders (12). Here, GPNMB is linked to obesity due to melanocortin 4 receptor deficiency.